1. Alfa Wassermann, Inc. (17 from 88 patents)

2. Novartis Ag (3 from 3,923 patents)

3. Zambon S.p.a. (1 from 78 patents)

4. Alfasigma S.p.a. (1 from 22 patents)

5. Camozzi Automation S.p.a. (6 patents)

6. Manuela Campana (0 patent)

7. Goffredo Rosini (0 patent)

8. Vincenzo Cannata (0 patent)

9. Dario Braga (0 patent)

10. Donatella Confortini (0 patent)

11. Giuseppe C. Viscomi (0 patent)

12. Denis Severini (0 patent)

13. Paolo Righi (0 patent)

1. 10703763 - Polymorphous forms of rifaximin, processes for their production and use thereof in the medicinal preparations

2. 9624192 - Carbamate/urea derivatives

3. 9498442 - Rifaximin powder, process for preparing the same an controlled release compositions containing said rifaximin useful for obtaining a long-lasting effect

4. 9452157 - Pharmaceutical compositions comprising rifaximin and amino acids, preparation methods and use thereof

5. 9273026 - Carbamate/urea derivatives

6. 9271968 - Polymorphous forms of rifaximin, processes for their production and use thereof in the medicinal preparations

7. 9034874 - Carbamate/urea derivatives

8. 8853231 - Pharmaceutical compositions comprising polymorphic forms α, β, and γ of rifaximin

9. 8835452 - Polymorphic forms α, β and γ of rifaximin

10. 8748447 - Rifaximin powder, process for preparing the same and controlled release compositions containing said rifaximin useful for obtaining a long-lasting effect

11. 8741904 - Polymorphous forms of rifaximin, processes for their production and use thereof in the medicinal preparations

12. 8518949 - Polymorphous forms of rifaximin, processes for their production and use thereof in the medicinal preparations

13. 8193196 - Polymorphous forms of rifaximin, processes for their production and use thereof in the medicinal preparations

14. 8173801 - Processes for the production of polymorphic forms of rifaximin

15. 8158644 - Pharmaceutical compositions comprising polymorphic forms α, β, and γ of rifaximin